REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/22/2025
Back to search
Official data from USPTO
DOSIMYCO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DOSIMYCO
ST13
US500000088429562Class
1, 5, 10, 42, 44
Filing
88429562
Registration
6224908
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
12/23/2025
Trademark type
Word
Nice classes
1, 5, 10, 42, 44
Filing date
05/14/2019
Registration date
12/22/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/22/2020
Last transaction
12/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Kyoto, JP
Examiner
ANKRAH,NAAKWAMA S
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. C. (pessoa física)
Representatives
Tomoko Nakajima Future IP LLC
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for biological researchbiotechnological researchmedical researchpharmaceutical researchveterinary research useincluding those comprised of natural materialsbut not for purposes of providing medical diagnosis or treatmentexcept fungicides; chemical preparationsstable isotope labeled reference standards for the analytical development of mass spectrometry methods for the biologicalbiotechnologicalmedicalpharmaceuticalveterinary research industries
Class 5
Diagnostic kits comprised of medical diagnostic chemical reagents for testing of body fluids and body tissue via high pressure liquid chromatographyfor use in detecting immunosuppressantanticoagulantinfectiousparasiticmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune system and nervous system related diseases and disorders; diagnostic kits comprised of medical diagnostic chemical reagents for testing of body fluids and body tissue via liquid chromatography coupled to tandem mass spectrometryfor use in detecting immunosuppressantanticoagulantinfectiousparasiticmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune system and nervous system related diseases and disorders
Class 10
Medical apparatus and instrumentsapparatus for blood analysismedical diagnostic apparatus for the analysis of body fluids and medical diagnostic apparatus for use in principal component analysis in biology for the analysis of body fluids; vitro diagnostic medical apparatus in the nature of mass spectrometers used in medical facilities
Class 42
Scientific research and development of molecules suitable for therapeutic use; scientific research and development of new procedures and experiments for the discoveryidentification or improvement of molecules suitable for therapeutic use; scientific and medical laboratory services; engineering services in the field of custom synthesis of molecules suitable for therapeutic use
Class 44
Medical diagnostic testing services
Publications
History of USPTO decisions and trademark events.
38 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/20/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/20/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/20/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/20/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/20/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/20/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/02/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/02/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/02/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/02/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/02/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/02/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/29/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/29/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/29/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/29/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/29/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/29/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/22/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/06/2020
PUBO
PUBLISHED FOR OPPOSITION
10/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/16/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/31/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/29/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/29/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/28/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/19/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/19/2020
CNSI
SUSPENSION INQUIRY WRITTEN
03/19/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/14/2020
ALIE
ASSIGNED TO LIE
02/24/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/01/2019
GNSL
LETTER OF SUSPENSION E-MAILED
08/01/2019
CNSL
SUSPENSION LETTER WRITTEN
08/01/2019
DOCK
ASSIGNED TO EXAMINER
07/30/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/30/2019
NWAP
NEW APPLICATION ENTERED
05/17/2019
Continuous trademark protection
Get notified about every new filing that threatens DOSIMYCO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.